Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
暂无分享,去创建一个
M. Dowsett | R. Luben | N. Wareham | K. Khaw | S. Bingham | A. Welch | N. Day | E. Folkerd
[1] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[2] S. Horie,et al. DHEA and testosterone in the elderly. , 2007, The New England journal of medicine.
[3] T. Perls. DHEA and testosterone in the elderly. , 2007, New England Journal of Medicine.
[4] Claudio Cobelli,et al. DHEA in elderly women and DHEA or testosterone in elderly men. , 2006, The New England journal of medicine.
[5] N. Day,et al. Work and leisure time physical activity assessed using a simple, pragmatic, validated questionnaire and incident cardiovascular disease and all-cause mortality in men and women: The European Prospective Investigation into Cancer in Norfolk prospective population study. , 2006, International journal of epidemiology.
[6] J. Murabito,et al. Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men , 2006, Annals of Internal Medicine.
[7] E. Ding,et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.
[8] J. Kaufman,et al. The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.
[9] D. Grobbee,et al. Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men , 2004, Circulation.
[10] H. Javitz,et al. Relationship of endogenous sex hormones to coronary heart disease: a twin study. , 2004, The Journal of clinical endocrinology and metabolism.
[11] G. B. Phillips,et al. Are major risk factors for myocardial infarction the major predictors of degree of coronary artery disease in men? , 2004, Metabolism: clinical and experimental.
[12] E. Barrett-Connor,et al. Time for (more research on) testosterone. , 2004, The Journal of clinical endocrinology and metabolism.
[13] A. Morgentaler,et al. Risks of testosterone-replacement therapy and recommendations for monitoring. , 2004, The New England journal of medicine.
[14] D. Blazer,et al. Testosterone and Aging , 2004 .
[15] L. Niskanen,et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. , 2003, European journal of endocrinology.
[16] D. Grobbee,et al. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men Society , 2003 .
[17] Jo Mitchell,et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study , 2003, Public Health Nutrition.
[18] David Handelsman,et al. Androgens and cardiovascular disease. , 2003, Endocrine reviews.
[19] A. von Eckardstein,et al. Androgens and coronary artery disease. , 2003, Endocrine reviews.
[20] K. Channer,et al. The vasodilatory action of testosterone: a potassium‐channel opening or a calcium antagonistic action? , 2003, British journal of pharmacology.
[21] A. Matsumoto,et al. Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks , 2003, Journal of the American Geriatrics Society.
[22] M. Bots,et al. Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.
[23] A. Hofman,et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. , 2002, The Journal of clinical endocrinology and metabolism.
[24] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[25] C. Huggins,et al. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.
[26] N. Skakkebaek,et al. Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin. , 2001, Metabolism: clinical and experimental.
[27] R. Steeds,et al. Chronic Stable Angina : A Randomized , Double-Blind , Placebo-Controlled Study Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With , 2000 .
[28] C. Hayward,et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. , 1999, Circulation.
[29] N. Day,et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.
[30] T. Key,et al. Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies , 1999, British Journal of Cancer.
[31] C. Webb,et al. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. , 1999, The American journal of cardiology.
[32] E. Vittinghoff,et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.
[33] M. Charles,et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. , 1997, The Journal of clinical endocrinology and metabolism.
[34] L. Kuller,et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.
[35] W. Bremner,et al. Androgens in men--uses and abuses. , 1996, The New England journal of medicine.
[36] S. Haffner. Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. , 1996, Hormone research.
[37] G. B. Phillips,et al. The association of hypotestosteronemia with coronary artery disease in men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[38] M. Barbagallo,et al. Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension , 1993, Journal of hypertension.
[39] J. Yarnell,et al. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[40] A. Vermeulen,et al. Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. , 1992, The Journal of clinical endocrinology and metabolism.
[41] E. Barrett-Connor,et al. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[42] J. Fleg,et al. Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men. , 1990, Journal of andrology.
[43] E. Barrett-Connor,et al. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. , 1988, Circulation.
[44] S. Haffner,et al. The relationship of sex hormones to hyperinsulinemia and hyperglycemia. , 1988, Metabolism: clinical and experimental.
[45] E. Barrett-Connor,et al. Blood pressure and endogenous testosterone in men: an inverse relationship. , 1988, Journal of hypertension.
[46] K. Yano,et al. Serum sex hormone levels and myocardial infarction in the Honolulu Heart Program. Pitfalls in prospective studies on sex hormones. , 1988, Journal of clinical epidemiology.
[47] P. Elwood,et al. Sex hormones, insulin, lipids, and prevalent ischemic heart disease. , 1987, American journal of epidemiology.
[48] L. Kuller,et al. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. , 1987, The American journal of cardiology.
[49] I. Murray-Lyon,et al. LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONE , 1977, The Lancet.
[50] G B Phillips,et al. Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[51] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.